Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Strategy lagged the Russell Midcap® Growth Index in the fourth quarter due to stock selection. While the performance was in line with the expectations for the full year. The firm believes that the Strategy underperformed in 2025 because it did not own Palantir Technologies Inc (PLTR). The Strategy focuses on achieving solid risk-adjusted returns by investing in high-quality compounders with fair valuations and market capitalizations between $2 billion and $50 billion at the time of purchase. Please review the Strategy’s top five holdings to gain insights into their key selections for 2025.
In its fourth-quarter 2025 investor letter, Brown Advisory Mid-Cap Growth Strategy highlighted stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) is a leading provider of scientific instruments and analytical and diagnostic solutions. On March 20, 2026, Bruker Corporation (NASDAQ:BRKR) stock closed at $33.30 per share. One-month return of Bruker Corporation (NASDAQ:BRKR) was -15.82%, and its shares lost 25.17% over the past 52 weeks. Bruker Corporation (NASDAQ:BRKR) has a market capitalization of $5.08 billion.
Brown Advisory Mid-Cap Growth Strategy stated the following regarding Bruker Corporation (NASDAQ:BRKR) in its fourth quarter 2025 investor letter:
“Bruker Corporation (NASDAQ:BRKR): Manufactures analytical and medical instruments. Bruker’s (BRKR) shares stabilized in late August after 18 months of decline from a never-ending string of industry headwinds (tariffs, NIH budgets, pharma pricing pressure). Modestly positive momentum returned during the quarter with the announcement of a handful of large equipment orders and positive commentary from other life science tools providers.”
Bruker Corporation (NASDAQ:BRKR) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 35 hedge fund portfolios held Bruker Corporation (NASDAQ:BRKR) at the end of the fourth quarter, compared to 50 in the previous quarter. Bruker Corporation (NASDAQ:BRKR) reported Q4 2025 revenue of $977.2 million, flat year over year. While we acknowledge the risk and potential of Bruker Corporation (NASDAQ:BRKR) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Bruker Corporation (NASDAQ:BRKR) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Bruker Corporation (NASDAQ:BRKR) and shared Artisan Small Cap Fund’s views on the company. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
